Fabricius, D.; Ludwig, C.; Scholz, J.; Rode, I.; Tsamadou, C.; Jacobsen, E.-M.; Winkelmann, M.; Grempels, A.; Lotfi, R.; Janda, A.;
et al. mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects. Vaccines 2021, 9, 918.
https://doi.org/10.3390/vaccines9080918
AMA Style
Fabricius D, Ludwig C, Scholz J, Rode I, Tsamadou C, Jacobsen E-M, Winkelmann M, Grempels A, Lotfi R, Janda A,
et al. mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects. Vaccines. 2021; 9(8):918.
https://doi.org/10.3390/vaccines9080918
Chicago/Turabian Style
Fabricius, Dorit, Carolin Ludwig, Judith Scholz, Immanuel Rode, Chrysanthi Tsamadou, Eva-Maria Jacobsen, Martina Winkelmann, Aline Grempels, Ramin Lotfi, Aleš Janda,
and et al. 2021. "mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects" Vaccines 9, no. 8: 918.
https://doi.org/10.3390/vaccines9080918
APA Style
Fabricius, D., Ludwig, C., Scholz, J., Rode, I., Tsamadou, C., Jacobsen, E.-M., Winkelmann, M., Grempels, A., Lotfi, R., Janda, A., Körper, S., Adler, G., Debatin, K.-M., Schrezenmeier, H., & Jahrsdörfer, B.
(2021). mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects. Vaccines, 9(8), 918.
https://doi.org/10.3390/vaccines9080918
